Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

Clinical trial NCT06413342 · RECRUITING

Trial details

NCT number: NCT06413342
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Chemoradiotherapy Sintilimab Immunotherapy Elderly Patients

Start date: 2024-06-01
Primary completion: 2026-06-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.